GINOBOLT-M2
March 28, 2026
GINOBOLT-MP2
March 28, 2026
GINOBOLT-MP1
₹890.00
Composition:
Glimepiride 1, Metformin Hydrochloride 500, Pioglitazone 15
Packaging Detail:
10 x 10
Description
A triple combination tablet for type 2 diabetes. It contains Glimepiride (insulin secretagogue), Metformin (insulin sensitizer), and Pioglitazone (insulin sensitizer) – three complementary agents targeting different aspects of diabetes pathophysiology.
Indications
Indications
-
Type 2 diabetes mellitus inadequately controlled on dual therapy.
-
As an adjunct to diet and exercise for comprehensive glycemic management.
Side Effects
Side Effects
-
Hypoglycemia (low blood sugar).
-
Fluid retention and edema (especially with Pioglitazone).
-
Weight gain.
-
Nausea and gastrointestinal disturbance.
-
Increased risk of bone fractures (in women, with Pioglitazone).
Reviews 0
Related products
-
VOMTIC
₹500.00 -
CEFIMOX-200
₹1,193.00 -
CEFLIDE-200
₹2,200.00
Reviews
There are no reviews yet.